Symbol
BTAI on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned
1,835,192 shares
Security Ownership %
8.4%

Millennium Management LLC ownership in BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI)

09 Feb 2026 - Millennium Management LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,835,192 shares of BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI). This represents 8.4% ownership of the company. In their previous filing dated 01 Oct 2025, INTEGRATED CORE STRATEGIES (US) LLC had reported owning 1,028,053 shares, indicating an increase of +79%. .